LYEL$10.82-0.60%
Lyell Immunopharma, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$265.02M
Float & O/S:24.15M / 24.51M
Inst Own:51.8%
DilutionScan read 55 of Lyell Immunopharma, Inc.'s SEC filings and found 1 ATM program, 8 shelf registrations and 4 completed offerings on file for LYEL. The latest dilution event on file is a registration statement on Jul 21, 2026. Analysis updated Nov 1, 2026.
